Exenatide/Pramlintide(Adocia)

N/A

Report date: 2023/01/07 22:56:38

Base Information

Drug NameExenatide/Pramlintide(Adocia)
Drug Alias NamePramExe
ClassificationBiologics > Protein drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsCalcitonin receptor agonistsIslet amyloid polypeptide stimulants
TargetsGlucagon-like peptide 1 receptorCalcitonin receptorIslet amyloid polypeptide
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdocia
China Registration ClassN/A

Develop Information

Active CompaniesAdocia
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A